Market Overview

BIOLASE Announces Participation At The 20th Annual Global Investment Conference In New York City September 4-6, 2018

Share:

BIOLASE Announces Participation At The 20th Annual Global Investment Conference In New York City September 4-6, 2018

PR Newswire

IRVINE, Calif., Aug. 22, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced it will be featured as a presenting company at the 20th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC.  The conference is being held on September 4-6, 2018 at the St. Regis New York Hotel in New York City.

BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.)

John Beaver, Executive Vice President and Chief Financial Officer of BIOLASE, will provide an overview of the Company's business during the live presentation and will be available to participate in one-on-one meetings with investors who are registered to attend the conference. 

If you are an institutional investor, and would like to attend the Company's presentation, please click on the following link (www.rodmanevents.com) to register for the conference.  Once your registration is confirmed, you will be prompted to log into the conference website to request a one-on-one meeting with the Company.

Event:  BIOLASE presentation
DateSeptember 4-6, 2018
Time12:30 pm (Eastern Time)
Location:  Fontainebleau Room (2nd floor); St. Regis New York Hotel

A live webcast and a 90-day replay of the presentation will be available on the BIOLASE Investor Events Page.

About BIOLASE, Inc.
BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including three-dimensional CAD/CAM intra-oral scanners and digital dentistry software. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 244 patented and 74 patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times.  BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients.  BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold over 37,600 laser systems to date in over 90 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer markets.

For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc and LinkedIn at www.linkedin.com/company/biolase.

BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/biolase-announces-participation-at-the-20th-annual-global-investment-conference-in-new-york-city-september-4-6-2018-300700730.html

SOURCE BIOLASE, Inc.

View Comments and Join the Discussion!